Daehwa Pharmaceutical Closes Slightly Weak in Regular Session... Rebounds 4.9% in After-Hours Trading (NXT)
Daehwa Pharmaceutical (067080) recorded a slight decline in the regular trading session on the 15th, finishing slightly weak. However, the stock shifted to an u

Daehwa Pharmaceutical (067080) recorded a slight decline in the regular trading session on the 15th, finishing slightly weak. However, the stock shifted to an upward trend in after-hours trading (NXT After-Market), drawing investor attention.
On the KOSDAQ market that day, Daehwa Pharmaceutical closed at 10,140 won, down 10 won (0.10%) from the previous trading day. During the session, the stock showed a somewhat stagnant movement with limited fluctuations centered around the 10,000-won level.
However, the trading atmosphere changed noticeably after the regular session closed. In the NXT After-Market, as of 4:14 p.m., the stock was trading at 10,650 won, surging 510 won (5.03%) compared to the regular session closing price. This figure also represents a 500-won (4.93%) increase from the previous day's closing price.
It is interpreted that buying pressure that had been on the sidelines during the regular session flowed into after-hours trading, causing the stock price to rebound strongly. The market is closely watching whether the upward momentum from this after-hours trading will lead to an improvement in investor sentiment going forward.
[Investment decisions are the responsibility of the individual investor, and this article should be used as reference material for making investment decisions.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.

![[Breaking] Enchem Pursues Reverse Triangular Merger with Nasdaq-Listed THE GROWHUB LIMITED Through U.S. Subsidiary... Accelerates Entry into U.S. Capital Markets](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581748/ed2a73c31f2e2200/variants/hero.webp)
![[Breaking] Enchem Surges 22% in After-Hours on News of U.S. Subsidiary Merger Plans; Focus Shifts to Regular Session Stock Movement on the 16th](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/07/587618/6d706435189d6b28/variants/hero.webp)